FR3037338B1 - Procede de greffe de cellule cardiaque sur la membrane choriallantoide d'œuf feconde - Google Patents

Procede de greffe de cellule cardiaque sur la membrane choriallantoide d'œuf feconde Download PDF

Info

Publication number
FR3037338B1
FR3037338B1 FR1555364A FR1555364A FR3037338B1 FR 3037338 B1 FR3037338 B1 FR 3037338B1 FR 1555364 A FR1555364 A FR 1555364A FR 1555364 A FR1555364 A FR 1555364A FR 3037338 B1 FR3037338 B1 FR 3037338B1
Authority
FR
France
Prior art keywords
cell
choriallantoid
grafting
cardiac cell
egg membrane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1555364A
Other languages
English (en)
Other versions
FR3037338A1 (fr
Inventor
Philippe Nirde
Sylvain Richard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amanda Finan-Marchi Fr
Philippe Nirde Fr
Sylvain Richard Fr
Original Assignee
Centre National de la Recherche Scientifique CNRS
Universite de Montpellier I
Institut National de la Sante et de la Recherche Medicale INSERM
Universite de Montpellier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS, Universite de Montpellier I, Institut National de la Sante et de la Recherche Medicale INSERM, Universite de Montpellier filed Critical Centre National de la Recherche Scientifique CNRS
Priority to FR1555364A priority Critical patent/FR3037338B1/fr
Priority to PCT/EP2016/063534 priority patent/WO2016198699A1/fr
Publication of FR3037338A1 publication Critical patent/FR3037338A1/fr
Application granted granted Critical
Publication of FR3037338B1 publication Critical patent/FR3037338B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0657—Cardiomyocytes; Heart cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0271—Chimeric vertebrates, e.g. comprising exogenous cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/12—Animals modified by administration of exogenous cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/30—Bird
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/035—Animal model for multifactorial diseases
    • A01K2267/0375—Animal model for cardiovascular diseases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/02—Coculture with; Conditioned medium produced by embryonic cells
    • C12N2502/025—Coculture with; Conditioned medium produced by embryonic cells extra-embryonic cells, e.g. amniotic epithelium, placental cells, Wharton's jelly
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/28—Vascular endothelial cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00—Use of cells in diagnostics
    • C12N2503/02—Drug screening
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/90—Substrates of biological origin, e.g. extracellular matrix, decellularised tissue
    • C12N2533/92—Amnion; Decellularised dermis or mucosa

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Environmental Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Microbiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La présente invention a pour objet un procédé de greffe d'au moins une cellule cardiaque ou d'au moins d'une cellule capable de se différentier en une cellule cardiaque sur la membrane chorioallantoïde vascularisée d'un œuf fécondé. La présente invention a également pour objet un procédé de caractérisation de l'activité d'un composé vis-à-vis du tissu cardiaque mettant en œuvre un œuf fécondé sur la membrane chorioallantoïde duquel a été greffé au moins une cellule cardiaque ou au moins d'une cellule capable de se différentier en une cellule cardiaque. La présente invention a également pour objet un kit comprenant un œuf fécondé sur lequel a été greffé au moins une cellule cardiaque ou au moins une cellule capable de se différentier en une cellule cardiaque.
FR1555364A 2015-06-12 2015-06-12 Procede de greffe de cellule cardiaque sur la membrane choriallantoide d'œuf feconde Expired - Fee Related FR3037338B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR1555364A FR3037338B1 (fr) 2015-06-12 2015-06-12 Procede de greffe de cellule cardiaque sur la membrane choriallantoide d'œuf feconde
PCT/EP2016/063534 WO2016198699A1 (fr) 2015-06-12 2016-06-13 Procede de greffe de cellule cardiaque sur la membrane choriallantoide d'oeuf feconde

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1555364 2015-06-12
FR1555364A FR3037338B1 (fr) 2015-06-12 2015-06-12 Procede de greffe de cellule cardiaque sur la membrane choriallantoide d'œuf feconde

Publications (2)

Publication Number Publication Date
FR3037338A1 FR3037338A1 (fr) 2016-12-16
FR3037338B1 true FR3037338B1 (fr) 2020-02-28

Family

ID=54478105

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1555364A Expired - Fee Related FR3037338B1 (fr) 2015-06-12 2015-06-12 Procede de greffe de cellule cardiaque sur la membrane choriallantoide d'œuf feconde

Country Status (2)

Country Link
FR (1) FR3037338B1 (fr)
WO (1) WO2016198699A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3105260A1 (fr) 2019-12-20 2021-06-25 Centre National De La Recherche Scientifique (Cnrs) Modèle organoïde cardiaque vascularisé apres incorporation de cardiomyocytes dérivés de cellules souches pluripotentes induites humaines

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3418297B1 (fr) 2005-12-13 2023-04-05 Kyoto University Facteur de reprogrammation nucléaire

Also Published As

Publication number Publication date
FR3037338A1 (fr) 2016-12-16
WO2016198699A1 (fr) 2016-12-15

Similar Documents

Publication Publication Date Title
MX2017016363A (es) Fenoxifenilamidinas sustituidas con halogeno y el uso de estas como fungicidas.
EA201692494A1 (ru) Композиции, содержащие липохитоолигосахарид и микроорганизм для усиления роста растения
EA201791444A1 (ru) 5-фтор-4-имино-3-(алкил/замещенный алкил)-1-(арилсульфонил)-3,4-дигидропиримидин-2(1h)-он в качестве средства обработки семян
EP3053931A3 (fr) Matrices chromatographie y compris ligands nouveaux staphylococcus aureus a base de protéines
NZ728529A (en) Fused 11-membered compounds and agricultural/horticultural fungicides containing them
WO2015200883A3 (fr) Banques de vnar de requin-nourrice semi-synthétiques pour la préparation et l'utilisation de composés de liaison sélectifs
MX2016009848A (es) Método de modulación de la galactosilación de proteína recombinante mediante optimización de medio de cultivo.
EA201792428A1 (ru) Гербицидные композиции, включающие l-глуфозинат и индазифлам
BR112017001978A2 (pt) grãos tratados com uma composição, método para reduzir danos, método para reduzir pós
EA201792538A1 (ru) Способ биологического получения метакриловой кислоты
EA202190078A1 (ru) Способ и устройство для приготовления силоса и силосования
EP3567115A4 (fr) Procédé biologique de préparation de fer hémique non dérivé du sang porcin
EA202090933A1 (ru) Способ получения гербицидных соединений пиридазинона
EA201892477A1 (ru) Препараты и способы для обработки фотосинтезирующих организмов и повышения их качества и урожайности с помощью препаратов композитов гликанов
FR3037338B1 (fr) Procede de greffe de cellule cardiaque sur la membrane choriallantoide d'œuf feconde
MX368327B (es) Sistemas y métodos para el genotipado de material vegetal.
CL2017003169A1 (es) Proceso de aislamiento de azúcares fermentables a partir del hidrolizado ácido de un material que contiene celulosa, hemicelulosa y lignina
MX2018000613A (es) Procedimiento para la preparacion de un producto fermentado de la leche.
FR3039035B1 (fr) Procede pour la preconisation des doses p (dp) d'engrais phosphorique pour grandues cultures agronomiques en presence de residus de culture au sol
FR3035794B1 (fr) Procede pour la purification du sang total ou d'un produit issu du sang
MX362298B (es) Proceso para la micropropagacion a escala comercial de vainilla (vanilla spp.) empleando biorreactores semiautomatizados.
FR3076184B1 (fr) Utilisation de derives de trehalose pour stimuler les defenses naturelles de plantes
EA201171078A1 (ru) Биотехнологический способ получения гемодеривата из телячьей крови и применение гемодеривата из телячьей крови
MX2021004298A (es) Metodos de sintesis de oxipicolinamidas.
IL289479A (en) Process for the production of (s)-3-hydroxy-1-(h1-indol-5-yl)-2-oxo-pyrrolidine-3-carboxylic acid 3, 5-difluoro-benzylamide

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20161216

PLFP Fee payment

Year of fee payment: 3

TQ Partial transmission of property

Owner name: PHILIPPE NIRDE, FR

Effective date: 20180330

Owner name: SYLVAIN RICHARD, FR

Effective date: 20180330

Owner name: AMANDA FINAN-MARCHI, FR

Effective date: 20180330

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

ST Notification of lapse

Effective date: 20220205